|View printer-friendly version|
|January 27, 2006 1:25 p.m.|
|Teva Announces Favorable Court Decision Regarding Generic Allegra. District Court Denies Motion for Preliminary Injunction|
Jerusalem, Israel, January 27, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. District Court for the District of New Jersey has denied a motion filed by Aventis Pharmaceuticals, Inc. and Albany Molecular Research, Inc. for a preliminary injunction related to Teva's Fexofenadine Hydrochloride Tablets, the AB-rated generic equivalent of Aventis' antihistamine Allegra® Tablets.